Pefloxacin
A fluoroquinolone antibiotic
| Pefloxacin | |
|---|---|
|
|
Pefloxacin is a fluoroquinolone antibiotic used to treat a variety of bacterial infections. It is a synthetic chemotherapeutic agent that is effective against a broad spectrum of Gram-positive and Gram-negative bacteria. Pefloxacin is particularly used in the treatment of urinary tract infections, respiratory tract infections, and gastrointestinal infections.
Pharmacology[edit]
Pefloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication and transcription. This inhibition leads to the disruption of bacterial cell division and ultimately results in bacterial cell death. The drug is bactericidal, meaning it kills bacteria rather than merely inhibiting their growth.
Administration and Dosage[edit]
Pefloxacin is typically administered orally in the form of tablets, but it can also be given intravenously in more severe cases. The dosage of pefloxacin depends on the type and severity of the infection, as well as the patient's renal function. It is important for patients to complete the full course of the antibiotic to prevent the development of antibiotic resistance.
Side Effects[edit]
Common side effects of pefloxacin include nausea, vomiting, diarrhea, and abdominal pain. Some patients may experience central nervous system effects such as headache, dizziness, and insomnia. Rare but serious side effects include tendonitis and tendon rupture, particularly in older adults and those on concurrent corticosteroid therapy.
Contraindications[edit]
Pefloxacin is contraindicated in patients with a known hypersensitivity to quinolones. It should be used with caution in patients with a history of seizures or other central nervous system disorders. The use of pefloxacin in pregnancy and breastfeeding is generally not recommended unless the potential benefits outweigh the risks.
Mechanism of Resistance[edit]
Bacterial resistance to pefloxacin can occur through several mechanisms, including mutations in the genes encoding DNA gyrase and topoisomerase IV, as well as efflux pumps that expel the drug from bacterial cells. The development of resistance is a significant concern and underscores the importance of appropriate antibiotic use.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian